Randall J. Bateman
Tracked across 3 events · 40 articles · First seen Feb 19, 2026 · Last active Sep 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Director and founder of C-BRAIN; leading Alzheimer's researcher at WashU Medicine.
Jul 13, 2026 · 6 articles
Tech
Impact: Randall J. Bateman is a co-founder of C2N Diagnostics and a coauthor of the study, contributing to the development of the blood test.
Feb 19, 2026 · 6 articles
Tech
The U.S. United States — Food and Drug Administration cleared the PrecivityAD2 blood test, developed by C2N Diagnostics, a startup founded by researchers at Washington University in St. Louis, to help evaluate Alzheimer's disease in…
Impact: Co-founded C2N Diagnostics and co-led development of the underlying technology; stated the clearance can increase early and accurate diagnoses.
Aug 21, 2026 · 28 articles
50
Randall J. Bateman co-founded startup C2N DiagnosticsFDA Clears C2N Alzheimer Blood Test
ERGEN INTELLIGENCE
Track Randall J. Bateman live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard